ArticleInternational journal of molecular sciences2023

Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice.

Arturo Cesaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.